Substrate-induced modulation of glutamate uptake in human platelets

British Journal of Pharmacology

Volumn 145, Issue 6, 2005, Pages 792-799

  Begni, Barbara ^a   Tremolizzo, Lucio ^a,b   D'Orlando, Cristina ^a   Bono, Maria Serena ^a   Garofolo, Rosanna ^a   Longoni, Marco ^a,b   Ferrarese, Carlo ^a,b  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b SAN GERARDO HOSPITAL   (Italy)

Author keywords

EAAT1; Glutamate uptake; Human platelets; Substrate modulation

Indexed keywords

3 HYDROXYASPARTIC ACID; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; AMINO ACID RECEPTOR BLOCKING AGENT; ASPARTIC ACID; CYCLOHEXIMIDE; DIHYDROKAINIC ACID; EXCITATORY AMINO ACID RECEPTOR; GLUTAMATE RECEPTOR AGONIST; GLUTAMIC ACID; GLUTAMIC ACID DERIVATIVE; PHOSPHOSERINE; RECEPTOR SUBTYPE;

AMINO ACID TRANSPORT; ARTICLE; BIOTINYLATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; EX VIVO STUDY; EXCITOTOXICITY; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; MOLECULAR MECHANICS; NEUROLOGIC DISEASE; PRIORITY JOURNAL; REGULATORY MECHANISM; SODIUM TRANSPORT; THROMBOCYTE FUNCTION; WESTERN BLOTTING;

AMINO ACID TRANSPORT SYSTEM X-AG; BLOOD PLATELETS; CYCLOHEXIMIDE; D-ASPARTIC ACID; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; EXCITATORY AMINO ACID TRANSPORTER 1; EXCITATORY AMINO ACID TRANSPORTER 2; GLUTAMATE PLASMA MEMBRANE TRANSPORT PROTEINS; GLUTAMIC ACID; GLYCINE; HUMANS; KAINIC ACID; SYMPORTERS;

EID: 23044482613     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706242     Document Type: Article

References (40)

1. ARRIZA, J.L., FAIRMAN, W.A., WADICHE, J.I., MURDOCH, G.H., KAVANAUGH, M.P. & AMARA, S.G. (1994). Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex. J. Neurosci., 14, 5559-5569.
2. BERK, M., PLEIN, H. & FERREIRA, D. (2001). Platelet glutamate receptor supersensitivity in major depressive disorder. Clin. Neuropharmacol., 24, 129-132.
3. BERNSTEIN, E.M. & QUICK, M.W. (1999). Regulation of gamma-aminobutyric acid (GABA) transporters by extracellular GABA. J. Biol. Chem., 274, 889-895.
4. BRIDGES, R.J., KAVANAUGH, M.P. & CHAMBERLIN, A.R. (1999). A pharmacological review of competitive inhibitors and substrates of high-affinity, sodium-dependent glutamate transport in the central nervous system. Curr. Pharm. Des., 5, 363-379.
5. CHOI, D.W. (1994). Glutamate receptors and the induction of excitotoxic neuronal death. Prog. Brain Res., 100, 47-51.
6. DA PRADA, M., CESURA, A.M., LAUNAY, J.M. & RICHARDS, J.G. (1988). Platelets as a model for neurones? Experientia, 44, 115-126.
7. DAVIS, K.E., STRAFF, D.J., WEINSTEIN, E.A., BANNERMAN, P.G., CORREALE, D.M., ROTHSTEIN, J.D. & ROBINSON, M.B. (1998). Multiple signalling pathways regulate cell surface expression and activity of the excitatory amino acid carrier 1 subtype of Glu transporter in C6 glioma. J. Neurosci., 67, 508-516.
8. DIAMOND, J.S. & JAHR, C.E. (1997). Transporters buffer synaptically released glutamate on a submillisecond time scale. J. Neurosci., 17, 4672-4687.
9. DI LUCA, M., COLCIAGHI, F., PASTORINO, L., BORRONI, B., PADOVANI, A. & CATTABENI, F. (2000). Platelets as a peripheral district where to study pathogenetic mechanism of Alzheimer disease: the case of amyloid precursor protein. Eur. J. Pharmacol., 405, 277-283.
10. DUAN, S., ANDERSON, C.M., STEIN, B.A. & SWANSON, R.A. (1999). Glutamate induced rapid upregulation of astrocyte glutamate transport and cell-surface expression of GLAST. J. Neurosci., 19, 10193-10200.
11. DUTUIT, M., TOURET, M., SZYMOCHA, R., NEHLIG, A., BELIN, M.F. & DIDIER-BAZES, M. (2002). Decreased expression of glutamate transporters in genetic absence epilepsy rats before seizure occurrence. J. Neurochem., 80, 1029-1038.
12. FERRARESE, C., PECORA, N., FRIGO, M., APOLLONIO, I. & FRATTOLA, L. (1993). Assessment of reliability and biological significance of glutamate levels in cerebrospinal fluid. Ann. Neurol., 33, 316-319.
13. FERRARESE, C., ZOIA, C., PECORA, N., PIOLTI, R., FRIGO, M., BIANCHI, G., SALA, G., BEGNI, B., RIVA, R. & FRATTOLA, L. (1999). Reduced platelet glutamate uptake in Parkinson's disease. J. Neur. Transm., 106, 685-692.
14. FERRARESE, C., BEGNI, B., CANEVARI, C., ZOIA, C., PIOLTI, R., FRIGO, M. & FRATTOLA, L. (2000). Glutamate uptake is decreased in platelets from Alzheimer's disease patients. Ann. Neurol., 47, 641-643.
15. FERRARESE, C., SALA, G., RIVA, R., BEGNI, B., ZOIA, C., TREMOLIZZO, L., GALIMBERTI, G., MILLUL, A., BASTONE, A., PENNINI, T., BALZARINI, C., FRATTOLA, L., BEGHI, E. & THE ITALIAN ALS STUDY GROUP (2001). Decreased platelet glutamate uptake in patients with amyotrophic lateral sclerosis. Neurology, 56, 270-272.
16. FRANCONI, F., MICELI, M., ALBERTI, L., SEGHIERI, G., DE MONTIS, M.G. & TAGLIAMONTE, A. (1998). Futher insights into the anti-aggregating activity of NMDA in human platelets. Br. J. Pharmacol., 124, 35-40.
17. GEGELASHVILI, G., CIVENNI, G., RACAGNI, G., DANBOLT, N.C., SCHOUSBOE, I. & SCHOUSBOE, A. (1996). Glutamate receptor agonist up-regulate glutamate transporter GLAST in astrocytes. Neuroreport, 8, 261-265.
18. GEGELASHVILI, G. & SCHOUSBOE, A. (1997). High affinity glutamate transporters: regulation of expression and activity. Mol. Pharmacol., 52, 6-15.
19. GEGELASHVILI, G., ROBINSON, M.B., TROTTI, D. & RAUEN, T. (2001). Regulation of glutamate transporters in health and disease. Prog. Brain Res., 132, 267-286.
20. GENEVER, P.G., WILKINSON, D.J.P., PATTON, A.J., PEET, N.M., HONG, Y., MATHUR, A., ERUSALIMSKY, J.D. & SKERRY, T.M. (1999). Expression of a functional N-methyl-D-aspartate-type glutamate receptor by bone marrow megakaryocytes. Blood, 23, 2876-2883.
21. KUO, J.S., CHEN, S.F., HUANG, H.J., YANG, C.S., TSAI, P.J. & HSUEH, C.M. (2001). The involvement of glutamate in recall of the conditioned NK cell response. J. Neuroimmunol., 118, 245-255.
22. MANGANO, R.M. & SCHWARCZ, R. (1981). The human platelet as a model for the glutamatergic neuron: platelet uptake of L-glutamate. J. Neurochem., 36, 1067-1076.
23. MARAGAKIS, N.J. & ROTHSTEIN, J.D. (2001). Glutamate transporters in neurologic disease. Arch. Neurol., 58, 365-370.
24. MASLIAH, E., ALFORD, M., DE TERESA, R., MALLORY, M. & HANSEN, L. (1996). Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease. Ann. Neurol., 40, 759-766.
25. +-dependent glutamate transport activity. Neurochem. Int., 37, 147-162.
26. O'SHEA, R.D. (2002). Roles and regulation of glutamate transporters in the central nervous system. Clin. Exp. Pharmacol. Physiol., 29, 1018-1023.
27. PLAITAKIS, A. & SHASHIDHARAN, P. (2000). Glutamate transport and metabolism in dopaminergic neurons of substantia nigra: implications for the pathogenesis of Parkinson's disease. J. Neurol., 247 (Suppl 2), II25-II35.
28. QIAN, Y., GALLI, A., RAMAMOORTHY, S., RISSO, S., DEFELICE, L.J. & BLAKELY, R.D. (1997). Protein kinasi C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression. J. Neurosci., 17, 45-57.
29. ROSSI, D.J., OSHIMA, T. & ATTWELL, D. (2000). Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature, 403, 316-321.
30. ROTHSTEIN, J.D., MARTIN, L.J. & KUNCL, R.W. (1992). Decrease glutamate transport by the brain and spinal cord in Amyotrophic Lateral Sclerosis. N. Engl. J. Med., 326, 1464-1469.
31. ROTHSTEIN, J.D., DYKES-HOBERG, M., PARDO, C.A., BRISTOL, L.A., JIN, L., KUNCL, R.W., KANAI, Y., HEDIGER, M.A., WANG, Y., SCHIELKE, J.P. & WELTY, D.F. (1996). Knockout of glutamate transporters reveals a major role for astroglial transport in excititoxicity and clearance of glutamate. Neuron, 16, 675-686.
32. +-dependent glutamate transporters by cAMP analogs and neurons. Mol. Pharmacol., 53, 355-369.
33. SCOTT, H.L., POW, D.V., TANNENBERG, A.E.G. & DODD, P.R. (2002). Aberrant expression of the glutamate transporter excitatory amino acid transporter 1 (EAAT1) in Alzheimer's disease. J. Neurosci., 22, RC206.
34. SKERRY, T.M. & GENEVER, P.O. (2001). Glutamate signalling in non-neuronal tissues. Trends Pharmacol. Sci., 22, 174-181.
35. SUAREZ, I., BODEGA, G. & FERNANDEZ, B. (2000). Modulation of glutamate transporters (GLAST, GLT-1 and EAAC1) in the rat cerebellum following portocaval anastomosis. Brain Res., 859, 293-302.
36. SWANSON, R.A., LIU, J., MILLER, J.W., ROTHSTEIN, J.D., PARREL, K., STEIN, B.A. & LONGUEMARE, M.C. (1997). Neuronal regulation of glutamate transporter subtype expression in astrocytes. J. Neurosci., 17, 932-940.
37. TANAKA, K., WATASE, K., MANABE, T., YAMADA, K., WATANABE, M., TAKAHASHI, K., IWAMA, H., NISHIKAWA, T., ICHIHARA, N., HORI, S., TAKIMOTO, M. & WADA, K. (1997). Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT1. Science, 276, 1699-1702.
38. TONG, G. & JAHR, C.E. (1994). Block of glutamate transporters potentiates postsynaptic excitation. Neuron, 13, 1195-1203.
39. YE, Z.C. & SONTHEIMER, H. (1999). Metabotropic glutamate receptor agonists reduce glutamate release from cultured astrocytes. Glia, 25, 270-281.
40. ZOIA, C., COGLIATI, T., TAGLIABUE, E., CAVALETTI, G., SALA, G., GALIMBERTI, G., RIVOLTA, I., ROSSI, V., FRATTOLA, L. & FERRARESE, C. (2004). Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer's disease. Neurobiol. Aging, 25, 149-157.